Skip to main content
Aflac10-Q: Recurring revenue shift

Aflac Japan sees new sales mix shift from 73% cancer products to 55% in one year

What happened

The contribution of cancer products to new sales dropped from 73.0% to 55.2% YoY, while medical and savings-type life insurance grew significantly. This rapid portfolio shift creates operational challenges and requires adjustments to marketing campaigns, agent training, and underwriting processes.

Source

SEC EDGARAug 7, 2026

Quarterly report (Form 10-Q)

Aflac 10-Q

Filing excerpt

The following table details the contributions to Aflac Japan's new annualized premium sales by major insurance product for the periods ended June 30. Three Months 2026 2025 Cancer 55.2 % 73.0 % Medical and other health 17.8 10.9 Life insurance: Tsumitasu 22.0 11.1

sec.gov/Archives/edgar/data/4977/000162828026054618/afl-20260630.htmRead the full source

Other signals in this filing (6)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Recurring revenue shift

What this signalsFilings often name leadership changes, deals and spending plans.

Fiscal year end
06/30
Filed
Aug 7, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Numbers

Percent
17.8% (Year-over-year decrease in cancer products' share of new sales mix (from 73.0% to 55.2%))

Details

CIK
4977
Accession number
0001628280-26-054618
Timeframe
Current quarter
Filing year
2026
Fiscal year
0
Why it matters
Billing/subscription tools

Topics and mentions

Regions named

  • Japan

Extraction

Confidence
High
Relevance
75%
Sentiment
Neutral
Detected
Aug 11, 2026
signal_type
sec-10q
signal_subtype
recurringRevenueShift

Use this data

Get every 10-Q signal for Aflac and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Aflac this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/a29e4c8c-fab9-42f2-b016-22db2285d949 returns this record as JSON. POST /v1/companies/enrich returns every signal for aflac.com.

{
  "signal_id": "a29e4c8c-fab9-42f2-b016-22db2285d949",
  "signal_type": "sec-10q",
  "signal_subtype": "recurringRevenueShift",
  "detected_at": "2026-08-11T08:05:00.406+00:00",
  "company": {
    "name": "Aflac",
    "domain": "aflac.com"
  },
  "data": {
    "detail": "The contribution of cancer products to new sales dropped from 73.0% to 55.2% YoY, while medical and savings-type life insurance grew significantly. This rapid portfolio shift creates operational challenges and requires adjustments to marketing campaigns, agent training, and underwriting processes.",
    "metrics": {
      "pct": 17.8,
      "timeframe": "current_quarter",
      "pct_context": "Year-over-year decrease in cancer products' share of new sales mix (from 73.0% to 55.2%)"
    },
    "summary": "Aflac Japan sees new sales mix shift from 73% cancer products to 55% in one year",
    "excerpts": "The following table details the contributions to Aflac Japan's new annualized premium sales by major insurance product for the periods ended June 30. Three Months 2026 2025 Cancer 55.2 % 73.0 % Medical and other health 17.8 10.9 Life insurance: Tsumitasu 22.0 11.1",
    "relevance": 0.75,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/4977/000162828026054618/afl-20260630.htm",
    "filing_date": "2026-08-07",
    "filing_year": 2026,
    "fiscal_year": 0,
    "fiscal_year_end": "06/30",
    "sales_relevance": "Billing/subscription tools",
    "signal_category": "revenue",
    "regions_mentioned": [
      "Japan"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.